A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients
- Status
- RECRUITING
- Phase
- PHASE2
Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS
- Status
- WITHDRAWN
- Phase
- PHASE1
Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients
- Status
- UNKNOWN
- Phase
- NA
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
- Status
- RECRUITING
- Phase
- PHASE2
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
- Status
- RECRUITING
- Phase
- NA
Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Status
- RECRUITING
- Phase
- PHASE1
Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
- Status
- RECRUITING
- Phase
- PHASE1
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
- Status
- RECRUITING
- Phase
- PHASE3
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2